Clinical trial

Lu AE58054 Added to Donepezil for the Treatment for Moderate Alzheimer's Disease

NCT01019421

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Lu AE58054 Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Placebo Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Lu AE58054 Added to Donepezil for the Treatment for Moderate Alzheimer's Disease

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2009-12-01

PhasePHASE2

Conditions

Alzheimer's Diseaseverified · MONDO: Alzheimer disease

Interventions

Lu AE58054DRUG

PlaceboDRUG

Sponsors & collaborators

H. Lundbeck A/Slead sponsor

Mapped research locations

PragueCzechia4 WarsawPoland3 MadridSpain2 BresciaItaly2 TorontoOntario, Canada1 BarcelonaSpain1 MilanItaly1 RomaItaly1 KrakowPoland1 LublinPoland1 LeipzigGermany1 BydgoszczPoland1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01019421 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.